Queen's University

Related Research

All Cancers

Neuro-innate-gut axis control of anti-cancer immunity

The best ideas often start with good questions. Experiments start with a why, and breakthroughs are often sparked by a what if. For example: Why do immunotherapies – treatments that harness our...
Read More
All Cancers

A collaborative approach to characterizing tumour immune microenvironments with multiplex immunofluorescence

A team of researchers led by Drs. Amber Simpson (Queen’s University) and Lillian Siu (Princess Margaret Cancer Centre, University Health Network) is hoping to develop a new technology to map th...
Read More
All Cancers

Tumour-host immunodynamics of Bacillus Calmette Guérin refractory bladder cancer

Bladder cancer is the fifth most common cancer in Canada, with 12,300 Canadians diagnosed in 2023. Smokers, men and older adults are at a higher risk, and numbers are expected to rise as our populatio...
Read More
Blood Cancers

Bone-sourced acute myeloid leukemia extracellular vesicles contribute to disease progression

How does the microenvironment affect how acute myeloid leukemia develops, and what new and improved therapies will help us to target it? A Queen’s University investigator aims to answer these qu...
Read More
Multiple Cancers

Neuroendocrine tumours (NETs) of the lung, prostate and pancreas

Sunnybrook Research Institute scientist Dr. Hon Leong says celebrities like Steve Jobs and Aretha Franklin, both diagnosed with rare neuroendocrine tumours, would have been among those to benefit from...
Read More
Completed

Brain Cancer

Modeling and therapeutic targeting of the clinical and genetic diversity in glioblastoma multiforme

Glioblastoma is a deadly brain cancer that currently has no cure, and has lagged behind major treatment advances other cancers have benefited from. But there’s hope: an Alberta-based, TFRI-funde...
Read More
Completed

Ovarian Cancer

Canadian ovarian cancer research consortium

Ovarian cancer is the fifth-leading cause of cancer-related deaths in the western world. More than one in four women do not respond to standard first-line chemotherapy treatment — an alarming nu...
Read More

Researchers

Jeremy Squire

Researcher
Lesley Seymour

Researcher
Lois Mulligan

Researcher
Madhuri Koti

Researcher
Sheela Abraham

Researcher
Neil M. Renwick

Researcher
Kathrin Tyryshkin

Researcher
David Berman

Researcher
Charles Graham

Researcher
Amber Simpson

Researcher
Tricia Cottrell

Researcher
Sofia Genta

Researcher
Sebastien Talbot

Researcher
Andrew Craig

Researcher
Chandrakant Tayade

Researcher